Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
Abstract Introduction Programmed cell death ligand-1 (PD-L1) expression is a promising biomarker for identifying treatment related to non-small cell lung cancer (NSCLC). Automated image analysis served as an aided PD-L1 scoring tool for pathologists to reduce inter- and intrareader variability. We d...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-021-02898-z |
id |
doaj-ba7f4e0e141342db950244bc4f0c4799 |
---|---|
record_format |
Article |
spelling |
doaj-ba7f4e0e141342db950244bc4f0c47992021-06-13T11:13:55ZengBMCJournal of Translational Medicine1479-58762021-06-0119111210.1186/s12967-021-02898-zAutomated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancerBoju Pan0Yuxin Kang1Yan Jin2Lin Yang3Yushuang Zheng4Lei Cui5Jian Sun6Jun Feng7Yuan Li8Lingchuan Guo9Zhiyong Liang10Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeSchool of Information Science and Technology, Northwest UniversityDepartment of Pathology, Fudan University Shanghai Cancer CenterSchool of Engineering, Westlake UniversityDepartment of Pathology, the First Affiliated Hospital of Soochow UniversitySchool of Information Science and Technology, Northwest UniversityDepartment of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeSchool of Information Science and Technology, Northwest UniversityDepartment of Pathology, Fudan University Shanghai Cancer CenterDepartment of Pathology, the First Affiliated Hospital of Soochow UniversityDepartment of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Introduction Programmed cell death ligand-1 (PD-L1) expression is a promising biomarker for identifying treatment related to non-small cell lung cancer (NSCLC). Automated image analysis served as an aided PD-L1 scoring tool for pathologists to reduce inter- and intrareader variability. We developed a novel automated tumor proportion scoring (TPS) algorithm, and evaluated the concordance of this image analysis algorithm with pathologist scores. Methods We included 230 NSCLC samples prepared and stained using the PD-L1(SP263) and PD-L1(22C3) antibodies separately. The scoring algorithm was based on regional segmentation and cellular detection. We used 30 PD-L1(SP263) slides for algorithm training and validation. Results Overall, 192 SP263 samples and 117 22C3 samples were amenable to image analysis scoring. Automated image analysis and pathologist scores were highly concordant [intraclass correlation coefficient (ICC) = 0.873 and 0.737]. Concordances at moderate and high cutoff values were better than at low cutoff values significantly. For SP263 and 22C3, the concordances in squamous cell carcinomas were better than adenocarcinomas (SP263 ICC = 0.884 vs 0.783; 22C3 ICC = 0.782 vs 0.500). In addition, our automated immune cell proportion scoring (IPS) scores achieved high positive correlation with the pathologists TPS scores. Conclusions The novel automated image analysis scoring algorithm permitted quantitative comparison with existing PD-L1 diagnostic assays and demonstrated effectiveness by combining cellular and regional information for image algorithm training. Meanwhile, the fact that concordances vary in different subtypes of NSCLC samples, which should be considered in algorithm development.https://doi.org/10.1186/s12967-021-02898-zPD-L1NSCLCAutomated scoringTPSMultistage ensemble strategy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Boju Pan Yuxin Kang Yan Jin Lin Yang Yushuang Zheng Lei Cui Jian Sun Jun Feng Yuan Li Lingchuan Guo Zhiyong Liang |
spellingShingle |
Boju Pan Yuxin Kang Yan Jin Lin Yang Yushuang Zheng Lei Cui Jian Sun Jun Feng Yuan Li Lingchuan Guo Zhiyong Liang Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer Journal of Translational Medicine PD-L1 NSCLC Automated scoring TPS Multistage ensemble strategy |
author_facet |
Boju Pan Yuxin Kang Yan Jin Lin Yang Yushuang Zheng Lei Cui Jian Sun Jun Feng Yuan Li Lingchuan Guo Zhiyong Liang |
author_sort |
Boju Pan |
title |
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer |
title_short |
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer |
title_full |
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer |
title_fullStr |
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer |
title_full_unstemmed |
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer |
title_sort |
automated tumor proportion scoring for pd-l1 expression based on multistage ensemble strategy in non-small cell lung cancer |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2021-06-01 |
description |
Abstract Introduction Programmed cell death ligand-1 (PD-L1) expression is a promising biomarker for identifying treatment related to non-small cell lung cancer (NSCLC). Automated image analysis served as an aided PD-L1 scoring tool for pathologists to reduce inter- and intrareader variability. We developed a novel automated tumor proportion scoring (TPS) algorithm, and evaluated the concordance of this image analysis algorithm with pathologist scores. Methods We included 230 NSCLC samples prepared and stained using the PD-L1(SP263) and PD-L1(22C3) antibodies separately. The scoring algorithm was based on regional segmentation and cellular detection. We used 30 PD-L1(SP263) slides for algorithm training and validation. Results Overall, 192 SP263 samples and 117 22C3 samples were amenable to image analysis scoring. Automated image analysis and pathologist scores were highly concordant [intraclass correlation coefficient (ICC) = 0.873 and 0.737]. Concordances at moderate and high cutoff values were better than at low cutoff values significantly. For SP263 and 22C3, the concordances in squamous cell carcinomas were better than adenocarcinomas (SP263 ICC = 0.884 vs 0.783; 22C3 ICC = 0.782 vs 0.500). In addition, our automated immune cell proportion scoring (IPS) scores achieved high positive correlation with the pathologists TPS scores. Conclusions The novel automated image analysis scoring algorithm permitted quantitative comparison with existing PD-L1 diagnostic assays and demonstrated effectiveness by combining cellular and regional information for image algorithm training. Meanwhile, the fact that concordances vary in different subtypes of NSCLC samples, which should be considered in algorithm development. |
topic |
PD-L1 NSCLC Automated scoring TPS Multistage ensemble strategy |
url |
https://doi.org/10.1186/s12967-021-02898-z |
work_keys_str_mv |
AT bojupan automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT yuxinkang automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT yanjin automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT linyang automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT yushuangzheng automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT leicui automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT jiansun automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT junfeng automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT yuanli automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT lingchuanguo automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer AT zhiyongliang automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer |
_version_ |
1721380055272128512 |